Impact of autologous stem cell transplant (ASCT) versus consolidation on health-related quality of life (HRQoL) for patients with multiple myeloma receiving carfilzomib maintenance: results from the cardamon trial
Popat, R. Wilson, W. Camilleri, M. Ramasamy, K. Streetly, M. Sive, J. Bygrave, C. Benjamin, R. Chapman, M. A. Chavda, S. J.
Popat, R.
Wilson, W.
Camilleri, M.
Ramasamy, K.
Streetly, M.
Sive, J.
Bygrave, C.
Benjamin, R.
Chapman, M. A.
Chavda, S. J.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Popat R, Wilson W, Camilleri M, Ramasamy K, Streetly M, Sive J, et al. Impact of Autologous Stem Cell Transplant (ASCT) Versus Consolidation on Health-Related Quality of Life (HRQoL) for Patients with Multiple Myeloma Receiving Carfilzomib Maintenance: Results from the Cardamon Trial. Blood. 2022 Nov;140:10191-2. PubMed PMID: WOS:000893230303086.